Toshihide Yokoyama

机构：Kurashiki Central Hospital · ORCID：0000-0002-5595-5010

发表论文 244 篇 · 总被引 6273 次 · h-index 28

代表论文

• Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study (2025 · The Lancet Oncology · 被引 6)
• Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutations (2025 · Lung Cancer · 被引 3)
• Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy (2025 · International Journal of Clinical Oncology · 被引 3)
• Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424L (2025 · Clinical Lung Cancer · 被引 2)
• Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101) (2026 · The Oncologist)
• A phase II study of DFP-14323, a non-specific immunomodulator, in combination with low-dose afatinib as first-line therapy for common EGFR mutation-positive NSCLC (2026 · Therapeutic Advances in Medical Oncology)